Sanofi’s Novavax NVAX Stock Holding History

Sanofi’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64.8M	Hold	6,880,481	–	–	12.14%	3
2026 Q1	$56M	Hold	6,880,481	–	–	16.67%	3
2025 Q4	$46.2M	Hold	6,880,481	–	–	14.9%	3
2025 Q3	$59.7M	Hold	6,880,481	–	–	22.91%	2
2025 Q2	$43.3M	Hold	6,880,481	–	–	24.67%	2
2025 Q1	$44.1M	Hold	6,880,481	–	–	26.58%	2
2024 Q4	$55.3M	Buy	+6,880,481	New	+$66.3M	31.73%	2

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sanofi's NVAX Position: Q2 2026 in Review

Sanofi held its Novavax (NVAX) position steady in Q2 2026 at 6,880,481 shares worth $64.8M. The position accounts for 12.14% of the portfolio, ranked #3.

Sanofi first reported a position in NVAX in Q4 2024 and has held it in 7 quarters since. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Sanofi held 6,880,481 shares of Novavax worth $64.8M as of Q2 2026.
Sanofi left its Novavax share count unchanged in Q2 2026.
Novavax made up 12.14% of Sanofi's portfolio in Q2 2026, its #3 holding.
Sanofi first reported a position in Novavax in Q4 2024 and has held it in 7 quarters since.
267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Sanofi's 13F filing for Q2 2026, filed 28 Jul 2026.